TELEFLEX INC(TFX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,354 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
TFX Stock Analysis & AI Quality Score
AI stock analysis and institutional research for TELEFLEX INC (TFX), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TFX at 30.5/100 on a 32-signal composite quality model, placing it at rank #2,354 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (26.0) and balance sheet strength (27.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), TELEFLEX INC reports quarterly revenue of $548.3M, net income of $-8.2M, free cash flow of $27.9M. Top institutional holders of TFX by reported 13-F value include BlackRock,, JANUS HENDERSON GROUP PLC, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. TFX trades on the NYSE exchange and files with the SEC under CIK 96943. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TFX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TELEFLEX INC directly from SEC EDGAR. TELEFLEX INC's 13F Pro composite quality score has ranged between 30 and 63 since 2021, currently 30.5 — a declining long-term trajectory across 28 quarterly and live scoring snapshots.
Revenue
Q1 2026
$548.3M
Net Income
Q1 2026
$-8.2M
Free Cash Flow
Q1 2026
$27.9M
D/E Ratio
Q1 2026
0.85
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+16.4% YoYNet Income
-354.2% YoYOperating Income
-54.2% YoYEPS (Diluted)
-368.9% YoYTotal Assets
-7.8% YoYTotal Debt
+42.8% YoY| Metric | FY 2025 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $1.99B +16.4% | $1.71B -38.6% | $2.79B -0.7% | $2.81B +10.7% | $2.54B -2.2% | $2.60B |
| Net Income | $-905.6M -354.2% | $356.3M -1.9% | $363.1M -25.2% | $485.4M +44.7% | $335.3M -27.3% | $461.5M |
| Operating Income | $118.4M -54.2% | $258.7M -48.2% | $499.7M -20.4% | $628.1M +48.5% | $423.1M -1.0% | $427.3M |
| EPS (Diluted) | $-20.25 -368.9% | $7.53 -2.0% | $7.68 -24.9% | $10.23 +44.3% | $7.09 -27.7% | $9.80 |
| Total Assets | $6.95B -7.8% | $7.53B +8.7% | $6.93B +0.8% | $6.87B -3.9% | $7.15B +13.4% | $6.31B |
| Total Debt | $2.84B +42.8% | $1.99B +5.5% | $1.89B -8.9% | $2.07B -22.7% | $2.68B +33.4% | $2.01B |
AI Insight: TFX Financial Trends
Debt surged 52% from Q2 2024 to Q3 2025 while cumulative net losses since Q4 2024 have eroded equity by roughly $1.5B, signaling a materially stressed balance sheet.
• Total debt climbed from $1,718M in Q2 2024 to $2,872M in Q3 2025, a 67% increase in five quarters.
• Equity deteriorated from $4,559M in Q2 2024 to $3,084M in Q1 2026, a $1,475M decline.
• Revenue dropped sharply to $548M in Q1 2026 from $913M in Q3 2025, the lowest quarterly figure in the dataset.
• Operating income recovered to $246M in Q4 2025 and $20M in Q1 2026 after a $-409M operating loss in Q3 2025.
⚠ Net losses in Q3 2025 ($-409M) and Q4 2025 ($-714M) suggest large impairment or restructuring charges — magnitude and recurrence warrant scrutiny.
⚠ Debt fell modestly from $2,872M in Q3 2025 to $2,617M in Q1 2026; whether deleveraging continues is a key inflection to monitor.
⚠ Q1 2026 revenue of $548M is the weakest in the dataset — confirm whether this reflects divestitures, seasonality, or demand deterioration.
AI Insight: TFX Ratio Trends
Massive impairment charges in Q3 2025 and Q4 2025 have cratered TFX's returns, with TTM ROE at -32.7% and ROIC near zero despite a modest Q1 2026 operating margin recovery to 3.7%.
• Operating margin collapsed from 19.9% in Q2 2025 to -44.8% in Q3 2025, driven by a large one-off charge, then partially recovered to 3.7% in Q1 2026.
• ROIC swung from 9.8% in Q2 2025 to -24.4% in Q3 2025 and sits at just 1.4% in Q1 2026, reflecting severely impaired capital productivity.
• Leverage has risen steadily: D/E expanded from 0.38 in Q2 2024 to 0.85 in Q1 2026, tightening the balance sheet amid earnings weakness.
• Net profit margin turned slightly negative at -1.5% in Q1 2026, a fragile improvement from -44.8% in Q3 2025 but still below pre-impairment levels.
⚠ Whether Q3 2025 and Q4 2025 charges are truly non-recurring — sustained sub-5% operating margins would signal structural deterioration, not a one-off.
⚠ D/E at 0.85 is more than double the Q2 2024 level of 0.38; rising leverage alongside negative ROE raises refinancing and covenant risk.
⚠ Q1 2026 operating margin recovery to 3.7% is encouraging but far below the 17–20% range seen in Q1–Q2 2025; pace of normalization is critical.
Get alerted when TFX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for TELEFLEX INC including:
Top Institutional Holders of TFX
BlackRock, Inc.
$644.9M5,391,991 shJANUS HENDERSON GROUP PLC
$513.3M4,291,311 shVANGUARD PORTFOLIO MANAGEMENT LLC
$291.6M2,438,183 shVANGUARD CAPITAL MANAGEMENT LLC
$237.3M1,983,824 shSessa Capital IM, L.P.
$182.6M1,526,228 shSTATE STREET CORP
$179.8M1,502,857 shFULLER & THALER ASSET MANAGEMENT, INC.
$163.1M1,363,950 shCITADEL ADVISORS LLC
$140.1M1,171,096 shCOOKE & BIELER LP
$136.7M1,142,674 shABRAMS BISON INVESTMENTS, LLC
$119.6M1,000,000 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $644.9M | 5,391,991 |
| JANUS HENDERSON GROUP PLC | $513.3M | 4,291,311 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $291.6M | 2,438,183 |
| VANGUARD CAPITAL MANAGEMENT LLC | $237.3M | 1,983,824 |
| Sessa Capital IM, L.P. | $182.6M | 1,526,228 |
| STATE STREET CORP | $179.8M | 1,502,857 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $163.1M | 1,363,950 |
| CITADEL ADVISORS LLC | $140.1M | 1,171,096 |
| COOKE & BIELER LP | $136.7M | 1,142,674 |
| ABRAMS BISON INVESTMENTS, LLC | $119.6M | 1,000,000 |
More Healthcare Companies
View all Healthcare →Put TFX on your watchlist
Track score changes the day TELEFLEX INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is TFX a good stock to buy?
13F Pro's AI-powered analysis of TELEFLEX INC (TFX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TFX are available on the TFX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own TFX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TFX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of TELEFLEX INC's investment landscape.